Genesis Therapeutics
Also operates as Genesis Molecular AI; builds the GEMS AI and laboratory platform for small-molecule drug discovery
Funding
$296.10M
2026
Details
Headquarters
San Mateo, United States
CEO
Evan Feinberg
Website
Milestones
FOUNDING YEAR
2019
Listed In
News
The latest coverage and announcements from Genesis Therapeutics.